{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0008283",
      "entity_text" : "proliferation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P68036",
      "entity_text" : "UBE2L3",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "UBE2L3 protein levels were strongly elevated in Ki-67 + proliferating B cells (p < 0.0001) (XREF_FIG D) and also increased in CD95 + (Fas / APO-1) activated B cells (p < 0.0001) (XREF_FIG E), consistent with a role for UBE2L3 regulated NF-kappaB activation in both B cell proliferation and activation.",
  "reading_complete" : "2020-08-08T12:01:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:59:36Z",
  "trigger" : "activated",
  "evidence" : [ "UBE2L3 protein levels were strongly elevated in Ki-67 +  proliferating B cells (p < 0.0001) ( XREF_FIG D) and also increased in CD95 +  (Fas/APO-1) activated B cells (p < 0.0001) ( XREF_FIG E), consistent with a role for UBE2L3-regulated NF-kappaB activation in both B cell proliferation" ],
  "pmc_id" : "4320258",
  "score" : 0
}